martes, 27 de mayo de 2014

Pre-Exposure Prophylaxis for Prevention of HIV | Public Health Grand Rounds | CDC

Pre-Exposure Prophylaxis for Prevention of HIV | Public Health Grand Rounds | CDC

Grand Rounds button
Dear Subscribers,

The video and presentation slides including Beyond the Data from the May session of CDC’s Public Health Grand Rounds, Pre-Exposure Prophylaxis (PrEP) for Prevention of HIV Infection, held on Tuesday, May 20 are now available at 
Each year, an estimated 50,000 individuals become infected with the human immunodeficiency virus (HIV) in the United States. A new prevention strategy, Pre-exposure Prophylaxis (PrEP), is intended for high-risk populations to reduce their risk of becoming infected with HIV. PrEP includes daily medication and routine follow-up. When used consistently, PrEP is shown to reduce the risk of HIV infection. If delivered effectively and used in combination with other proven prevention methods, PrEP may help address the HIV epidemic in the United States.

Viewers joined us as we explored the opportunities for using PrEP as another tool to prevent the transmission of HIV and discuss the challenges to effective implementation that must be addressed.

Continuing Education
Continuing education for Grand Rounds is available and ALL Continuing Education for Grand Rounds are issued online through the CDC/ATSDR Training & Continuing Education Online system. If you have questions, email or call Learner Support at 1-800-418-7246 (1-800-41TRAIN).

Learn more about continuing education on the Grand Rounds website.

Future Grand Rounds Topics
June – Hepatitis C Virus: Looking Back to Look Forward
July – Public Health Approaches to Reduce U.S. Infant Mortality, an encore presentation

No hay comentarios:

Publicar un comentario